Institutional Capital’s Pfizer PFE Stock Holding History

Institutional Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$17M	Sell	552,054 -70,185	-11%	-$2.14M	0.25%	46
2016 Q3	$20M	Hold	622,239	–	–	0.28%	47
2016 Q2	$20.8M	Buy	622,239 +11,225	+2%	+$358K	0.25%	44
2016 Q1	$17.2M	Buy	611,014 +128,545	+27%	+$3.67M	0.18%	43
2015 Q4	$14.8M	Buy	+482,469	New	+$15.2M	0.13%	44
2015 Q3	–	Sell	-8,957,349	Closed	-$285M	–	50
2015 Q2	$285M	Sell	8,957,349 -11,396,940	-56%	-$371M	1.99%	25
2015 Q1	$672M	Sell	20,354,289 -8,547,130	-30%	-$272M	4.13%	4
2014 Q4	$854M	Sell	28,901,419 -5,396,786	-16%	-$155M	5.14%	3
2014 Q3	$962M	Sell	34,298,205 -6,600,827	-16%	-$185M	5.62%	2
2014 Q2	$1.15B	Sell	40,899,032 -1,968,460	-5%	-$56.1M	5.46%	2
2014 Q1	$1.31B	Buy	42,867,492 +1,019,741	+2%	+$30.4M	6.15%	1
2013 Q4	$1.22B	Sell	41,847,751 -204,975	-0.5%	-$5.97M	5.88%	2
2013 Q3	$1.15B	Sell	42,052,726 -2,029,343	-5%	-$55.2M	5.87%	1
2013 Q2	$1.17B	Buy	+44,082,069	New	+$1.22B	6.05%	1

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Institutional Capital's PFE Position: Q4 2016 in Review

Institutional Capital reduced its Pfizer (PFE) stake by 11% in Q4 2016, selling an estimated $2.14M and leaving 552,054 shares worth $17M. The position accounts for 0.25% of the portfolio, ranked #46.

Institutional Capital first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.31B in Q1 2014. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Institutional Capital held 552,054 shares of Pfizer worth $17M as of Q4 2016.
Institutional Capital sold 70,185 Pfizer shares in Q4 2016, an estimated $2.14M.
Pfizer made up 0.25% of Institutional Capital's portfolio in Q4 2016, its #46 holding.
Institutional Capital first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Institutional Capital's Pfizer position peaked at $1.31B in Q1 2014.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Institutional Capital's 13F filing for Q4 2016, filed 2 Feb 2017.